These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3766407)

  • 21. Calcium influx through L-type channels attenuates skeletal muscle contraction via inhibition of adenylyl cyclases.
    Menezes-Rodrigues FS; Pires-Oliveira M; Duarte T; Paredes-Gamero EJ; Chiavegatti T; Godinho RO
    Eur J Pharmacol; 2013 Nov; 720(1-3):326-34. PubMed ID: 24140436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.
    Antman EM; Stone PH; Muller JE; Braunwald E
    Ann Intern Med; 1980 Dec; 93(6):875-85. PubMed ID: 6255848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of calcium channel blockers on sinoatrial conduction in the isolated and blood-perfused dog atrium.
    Kobayashi M; Shimotori M; Ogiwara Y; Chiba S
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):72-82. PubMed ID: 3485962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular action of calcium channel blocking drugs.
    Schwartz A; Triggle DJ
    Annu Rev Med; 1984; 35():325-39. PubMed ID: 6372660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.
    Lee KS; Tsien RW
    Nature; 1983 Apr; 302(5911):790-4. PubMed ID: 6302512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine.
    Pearigen PD; Benowitz NL
    Drug Saf; 1991; 6(6):408-30. PubMed ID: 1793522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanism of action of calcium-antagonists on the smooth vascular muscles].
    Ferrari R; Cargnoni A; Rodella A; Ciampalini G; Raddino R
    Cardiologia; 1985 May; 30(5):347-56. PubMed ID: 2421900
    [No Abstract]   [Full Text] [Related]  

  • 32. Calcium channel blocking agents: physiologic basis of nursing intervention.
    Touloukian JE
    Heart Lung; 1985 Jul; 14(4):342-50. PubMed ID: 3891687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectivity of calcium antagonistic action in vascular smooth muscle.
    van Breemen C; Mangel A; Fahim M; Meisheri K
    Am J Cardiol; 1982 Feb; 49(3):507-10. PubMed ID: 6277176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle.
    Metzger H; Stern HO; Pfitzer G; Rüegg JC
    Arzneimittelforschung; 1982; 32(11):1425-7. PubMed ID: 6891247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Ca++-channel blocking agents on calcium transients and tension development in isolated mammalian heart muscle.
    Morgan JP; Wier WG; Hess P; Blinks JR
    Circ Res; 1983 Feb; 52(2 Pt 2):I47-52. PubMed ID: 6831653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive mechanism of action and binding sites of nitrendipine.
    Triggle DJ
    Am J Cardiol; 1986 Sep; 58(8):35D-38D. PubMed ID: 2429539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-type Ca2+ channel blockers inhibit the window contraction of mouse aorta segments with high affinity.
    Michiels CF; Van Hove CE; Martinet W; De Meyer GR; Fransen P
    Eur J Pharmacol; 2014 Sep; 738():170-8. PubMed ID: 24886884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal and spatial dynamics underlying capacitative calcium entry in human colonic smooth muscle.
    Kovac JR; Chrones T; Sims SM
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G88-98. PubMed ID: 17975132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.